Name: MURAL ONCOLOGY PLC (MURA) Stock
Brand: MURAL ONCOLOGY PLC
Rating: 2 (3 reviews)

MURA Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill - Mentions: DBVT MYSZ EB JSPR ...

These stocks have an unusual volume in today's session

10 hours ago - By: Mural Oncology plc - Mentions: XOMA

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

10 hours ago - By: Mural Oncology plc

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

2 days ago - By: Mural Oncology plc

Mural Oncology Announces Sanction of the Scheme by the High Court

2 days ago - By: Mural Oncology plc

Mural Oncology Announces Sanction of the Scheme by the High Court

9 days ago - By: Mural Oncology plc - Mentions: XOMA

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

9 days ago - By: Mural Oncology plc

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

a month ago - By: Mural Oncology plc - Mentions: XOMA

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

a month ago - By: Mural Oncology plc

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

2 months ago - By: Halper Sadeh LLC - Mentions: PHLT ARIS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

2 months ago - By: Mural Oncology plc

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

2 months ago - By: Mural Oncology plc

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

2 months ago - By: Halper Sadeh LLC - Mentions: ARIS MTSR GTLS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

3 months ago - By: Halper Sadeh LLC - Mentions: NWE GES TZUP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders

4 months ago - By: Halper Sadeh LLC

MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders

4 months ago - By: Stocktwits - Mentions: XOMA

Mural Oncology To Be Acquired By Xoma Royalty

4 months ago - By: Mural Oncology plc

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

4 months ago - By: The Motley Fool

Mural Oncology (MURA) Q2 Loss Widens 49%

4 months ago - By: Mural Oncology plc

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

4 months ago - By: Mural Oncology plc

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

4 months ago - By: Benzinga - Mentions: PTIX SRPT REPL HCTI ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

7 months ago - By: Mural Oncology plc

Mural Oncology Announces Number of Relevant Securities in Issue

7 months ago - By: Mural Oncology plc

FORM 8.1(a) & (b) - Mural Oncology plc

8 months ago - By: Stocktwits

Mural Oncology's Retail Buzz Explodes After Micro-Cap Biotech Mulls Strategic Alternatives

8 months ago - By: Benzinga

Mural Oncology Shares Surge As Company Explores Strategic Alternatives: What's Going On?

8 months ago - By: Mural Oncology, Inc.

MURAL ONCOLOGY PLC (MURA) Stock News

MURA Latest News, Press Relases and Analysis

These stocks have an unusual volume in today's session

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

Mural Oncology Announces Sanction of the Scheme by the High Court

Mural Oncology Announces Sanction of the Scheme by the High Court

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders

MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders

Mural Oncology To Be Acquired By Xoma Royalty

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Mural Oncology (MURA) Q2 Loss Widens 49%

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Mural Oncology Announces Number of Relevant Securities in Issue

FORM 8.1(a) & (b) - Mural Oncology plc

Mural Oncology's Retail Buzz Explodes After Micro-Cap Biotech Mulls Strategic Alternatives

Mural Oncology Shares Surge As Company Explores Strategic Alternatives: What's Going On?

Mural Oncology Announces Plans to Explore Strategic Alternatives